GlassScriptPhysician profile
Benjamin N Askin
NPI 1285195370
$7,508.54
in general payments reported to CMS, 2019-2025
19 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $2,556 · 2021: $1,717 · 2022: $2,492 · 2023: $126 · 2024: $185 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $3,621.27 | 2020-2021 | |
| Stryker Corporation | $2,317.78 | 2019-2023 | Citrefix |
| Smith+Nephew, INC. | $524.84 | 2019-2025 | Stravix Mesh, Stravix Pl, Grafix Pl |
| Organogenesis INC. | $302.11 | 2022-2025 | Puraply, Via Matrix |
| Zimmer Biomet Holdings, INC. | $248.76 | 2019-2022 | |
| Kci USA, INC. | $73.49 | 2019-2021 | |
| Treace Medical Concepts, INC. | $67.79 | 2023-2024 | |
| Pacira Pharmaceuticals Incorporated | $67.61 | 2021 | |
| Nevro Corp. | $63.05 | 2022-2023 | Senza |
| Acera Surgical, INC. | $49.65 | 2022 | |
| Paratek Pharmaceuticals, INC. | $28.18 | 2021-2022 | |
| Eclipse Technology Solutions INC. | $28.18 | 2025 | |
| Paragon 28, INC. | $21.90 | 2023 | Gorilla |
| Integra Lifesciences Corporation | $20.78 | 2019 | |
| Lifenet Health | $16.28 | 2025 | Theragenesis Wound Matrix |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrofera LLC | $15.12 | 2022 | |
| Melinta Therapeutics, LLC | $15.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.92 | 2020 | |
| Bioventus LLC | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Askin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.